Browse Items (19 total)
- Tags: Resveratrol
Inhibition Of Apoptosis In Human Retinal Pigment Epithelial Cells Treated With Benzo(e)pyrene, A Toxic Component Of Cigarette Smoke
Tags: 2010, alzheimers-disease, dna-damage, Estrago-Franco M F, experimental glaucoma, genistein, Gupta N, Investigative ophthalmology & visual science, Kenney M C, Kuppermann B D, macular degeneration, Mansoor S, memantine treatment, Migon R, Mitochondrial dysfunction, Ophthalmology, Oxidative Stress, Patil A J, protects, Ramirez C, Resveratrol, Sapkal A
Alteration of hepatic proinflammatory cytokines is involved in the resveratrol-mediated chemoprevention of chemically-induced hepatocarcinogenesis.
Tags: 2012, Animals, Anticarcinogenic Agents/pharmacology/*therapeutic use, Awale Prabha, Bhatia Deepak, Bishayee Anupam, Carroll Richard T, Current pharmaceutical biotechnology, Cytokines/genetics/*metabolism, Darvesh Altaf S, Department of Pharmaceutical Sciences, Diethylnitrosamine, Experimental/chemically induced/metabolism/*prevention & control, Female, Geldenhuys Werner J, Gene Expression Regulation/drug effects, Liver Neoplasms, Liver/drug effects/metabolism, Mbimba Thomas, Messenger/metabolism, NEOMED College of Pharmacy, Phenobarbital, Rats, Resveratrol, RNA, Sprague-Dawley, Stilbenes/pharmacology/*therapeutic use
Natural products of dietary origin as lead compounds in virtual screening and drug design.
Tags: *Biological Products/pharmacology, *Drug Design, 2012, Animals, Bishayee Anupam, Caffeine/pharmacology, Carroll Richard T, Curcumin/pharmacology, Current pharmaceutical biotechnology, Darvesh Altaf S, Department of Pharmaceutical Sciences, Diet, Geldenhuys Werner J, Genistein/pharmacology, Humans, NEOMED College of Pharmacy, Resveratrol, Stilbenes/pharmacology
CArG-driven GADD45alpha activated by resveratrol inhibits lung cancer cells.
Resveratrol suppresses oxidative stress and inflammatory response in diethylnitrosamine-initiated rat hepatocarcinogenesis.
Tags: 2010, Animals, Antioxidants/*pharmacology/therapeutic use, Antitumor, Barnes Kendra F, Bhatia Deepak, Bishayee Anupam, Cancer prevention research (Philadelphia, Pa.), Carcinogens/toxicity, Carroll Richard T, Chemical and Drug Induced Liver Injury/*etiology/metabolism/pathology, Darvesh Altaf S, Department of Pharmaceutical Sciences, Diethylnitrosamine/toxicity, Dose-Response Relationship, Drug, Drug Screening Assays, Enzyme Induction/drug effects, Experimental/chemically induced/metabolism/pathology/*prevention & control, Female, Hyperplasia, Inflammation/*prevention & control, Lipid Peroxidation/drug effects, Liver Neoplasms, Liver/drug effects/metabolism/pathology, Messenger/biosynthesis/genetics, NEOMED College of Pharmacy, NF-E2-Related Factor 2/biosynthesis/genetics, Nitric Oxide Synthase Type II/biosynthesis/genetics, Oxidative Stress/*drug effects, Phenobarbital/toxicity, Precancerous Conditions/*chemically induced/metabolism/pathology, Rats, Resveratrol, RNA, Sprague-Dawley, Stilbenes/*pharmacology/therapeutic use, Tyrosine/analogs & derivatives/analysis
Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials.
Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol.
Tags: 2005, 70-kDa/metabolism, American journal of physiology. Heart and circulatory physiology, Angiotensin II/pharmacology, Animals, Antioxidants/*pharmacology, Bomser Joshua A, Cell Differentiation/drug effects, Cell Division/drug effects, Cells, Cultured, Department of Integrative Medical Sciences, Drug Interactions, Epidermal Growth Factor/pharmacology, Fibroblasts/*cytology/*drug effects, Male, Meszaros J Gary, Mitogen-Activated Protein Kinase 1/metabolism, Mitogen-Activated Protein Kinase 3/metabolism, Myocardium/*cytology, Naugle Jennifer E, NEOMED College of Medicine, Olson Erik R, Protein-Serine-Threonine Kinases/metabolism, Proto-Oncogene Proteins c-akt, Proto-Oncogene Proteins/metabolism, Rats, Resveratrol, Ribosomal Protein S6 Kinases, Signal Transduction/drug effects, Sprague-Dawley, Stilbenes/*pharmacology, Vasoconstrictor Agents/pharmacology, Zhang Xiaojin
Resveratrol and liver disease: from bench to bedside and community.
Tags: 2010, Acetaminophen/metabolism, Anti-Inflammatory Agents, Antioxidants/therapeutic use, Bishayee Anupam, Carbon Tetrachloride/metabolism, Cytokines/metabolism, Darvesh Altaf S, Department of Pharmaceutical Sciences, Ethanol/metabolism, Free Radicals/metabolism, Glutathione/metabolism, Hepatocytes/drug effects/pathology, Humans, Liver Diseases/*drug therapy/epidemiology, Liver international : official journal of the International Association for the Study of the Liver, McGory Robb, NEOMED College of Pharmacy, NF-kappa B/antagonists & inhibitors, Non-Steroidal/therapeutic use, Politis Themos, Resveratrol, Stilbenes/pharmacokinetics/*pharmacology/therapeutic use/toxicity
Resveratrol inhibition of Propionibacterium acnes.
Tags: *Anti-Bacterial Agents, 2007, Anti-Inflammatory Agents, Bailey Erin, Benzoyl Peroxide/pharmacology, Booth Tristan D, Department of Family & Community Medicine, Docherty John J, Dose-Response Relationship, Drug, Erythromycin/pharmacology, Keratolytic Agents/pharmacology, McEwen Heather A, Microbial Sensitivity Tests, NEOMED College of Medicine, Non-Steroidal/*pharmacology, Propionibacterium acnes/*drug effects/growth & development, Resveratrol, Stilbenes/*pharmacology, Sweet Thomas J, The Journal of antimicrobial chemotherapy
Resveratrol inhibition of herpes simplex virus replication.
Tags: 1999, Animals, Antiviral Agents/*pharmacology/toxicity, Antiviral research, Cell Cycle/drug effects, Cell Line, Cercopithecus aethiops, DeLucia A L, Department of Integrative Medical Sciences, Docherty J J, Fu M M, Herpesvirus 1, Herpesvirus 2, Human/*drug effects/physiology, Humans, Immediate-Early Proteins/antagonists & inhibitors/biosynthesis, Limperos R J, Mice, NEOMED College of Medicine, Pokabla C M, Resveratrol, Stiffler B S, Stilbenes/*pharmacology/toxicity, Vero Cells, Virus Latency/drug effects/physiology, Virus Replication/*drug effects/physiology
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma.
Tags: 2010, Anticarcinogenic Agents/*therapeutic use, Antineoplastic Agents – Therapeutic Use, Bishayee Anupam, Cancer treatment reviews, Carcinoma, Darvesh Altaf S, Department of Pharmaceutical Sciences, Hepatocellular – Drug Therapy, Hepatocellular – Prevention and Control, Hepatocellular/*drug therapy/*prevention & control, Humans, Liver Neoplasms – Drug Therapy, Liver Neoplasms – Prevention and Control, Liver Neoplasms/*drug therapy/*prevention & control, NEOMED College of Pharmacy, Politis Themos, Resveratrol, Stilbenes – Therapeutic Use, Stilbenes/*therapeutic use
Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis.
Tags: 2009, Animal, Animals, Anticarcinogenic Agents/*antagonists & inhibitors/pharmacology, Antitumor, Apoptosis/*drug effects, Bishayee Anupam, Body Weight/drug effects, Cell Proliferation/drug effects, Chemico-biological interactions, Dhir Neetika, Diethylnitrosamine, Disease Models, Dose-Response Relationship, Drinking/drug effects, Drug, Drug Screening Assays, Eating/drug effects, Experimental/chemically induced/pathology/*prevention & control, Female, Immunohistochemistry, Liver Neoplasms, Organ Size/drug effects, Phenobarbital, Proto-Oncogene Proteins c-bcl-2/biosynthesis, Rats, Resveratrol, Sprague-Dawley, Stilbenes/*pharmacology
Resveratrol inhibition of varicella-zoster virus replication in vitro.
Tags: 2006, Antiviral Agents/*pharmacology, Antiviral research, Bailey Erin, Blotting, Booth Tristan, Cell Line, Docherty John J, Dose-Response Relationship, Drug, Faith Seth A, Fibroblasts/virology, Herpesvirus 3, Human/*drug effects/physiology, Humans, Immediate-Early Proteins/biosynthesis, Messenger/biosynthesis, Resveratrol, Reverse Transcriptase Polymerase Chain Reaction, RNA, Stilbenes/*pharmacology, Sweet Thomas J, Trans-Activators/biosynthesis, Viral Envelope Proteins/biosynthesis, Viral Plaque Assay, Viral/biosynthesis, Virus Attachment/drug effects, Virus Inactivation/drug effects, Virus Replication/*drug effects, Western
Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Tags: 2006, Animals, Antiviral Agents/*pharmacology, Antiviral research, Bailey Erin, Booth Tristan, Cell Nucleus/chemistry, Cercopithecus aethiops, Cytoplasm/chemistry, DNA, Docherty John J, Electrophoretic Mobility Shift Assay, Faith Seth A, Fluorescence, Herpesvirus 1, Herpesvirus 2, Human/drug effects/genetics/*growth & development, Human/drug effects/genetics/*physiology, I-kappa B Proteins/metabolism, Messenger/biosynthesis, Microscopy, NF-kappa B/*metabolism, NF-KappaB Inhibitor alpha, Polymerase Chain Reaction, Resveratrol, Reverse Transcriptase Polymerase Chain Reaction, RNA, Stilbenes/*pharmacology, Sweet Thomas J, Transcription Factor RelA/metabolism, Vero Cells, Viral/biosynthesis, Virus Replication/*drug effects
Effect of resveratrol on herpes simplex virus vaginal infection in the mouse.
Tags: 2005, Animals, Antiviral Agents/administration & dosage/pharmacology/*therapeutic use, Antiviral research, Booth Tristan, Docherty John J, Drug Evaluation, Faith Seth A, Female, Fu Ming Ming, Hah Jennifer M, Herpes Genitalis/*drug therapy/pathology/virology, Herpesvirus 1, Herpesvirus 2, Human/*drug effects/physiology, Human/drug effects/isolation & purification/physiology, Mice, Placebos, Preclinical, Resveratrol, Stilbenes/administration & dosage/pharmacology/*therapeutic use, Survival Analysis, Sweet Thomas J, Vaginal Diseases/*drug therapy/virology, Viral Plaque Assay, Virus Replication/drug effects
Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice.
Tags: 2004, Acyclovir/administration & dosage/pharmacology/therapeutic use, Administration, Animals, Antiviral Agents/administration & dosage/pharmacology/*therapeutic use/toxicity, Antiviral research, Booth Tristan, Docherty John J, Drug Resistance, Fatty Alcohols/administration & dosage/pharmacology/therapeutic use, Fu Ming Ming, Hairless, Herpes Simplex/*drug therapy, Herpesvirus 1, Human/*drug effects/growth & development, Mice, Resveratrol, Smith Jennifer S, Stilbenes/administration & dosage/*pharmacology/*therapeutic use/toxicity, Stoner Terri, Topical, Viral
Suppression of the inflammatory cascade is implicated in resveratrol chemoprevention of experimental hepatocarcinogenesis.
Tags: 2010, Animals, Anticarcinogenic Agents/*therapeutic use, Barnes Kendra F, Bhatia Deepak, Bishayee Anupam, Chatterjee Malay, Chemoprevention, Cyclooxygenase 2/immunology, Darvesh Altaf S, Department of Pharmaceutical Sciences, Diethylnitrosamine, Female, HSP70 Heat-Shock Proteins/immunology, Humans, Inflammation/prevention & control, Liver Neoplasms/chemically induced/*immunology/*prevention & control, Liver/drug effects/pathology, Mbimba Thomas, NEOMED College of Pharmacy, NF-kappa B/immunology, Pharmaceutical research, Rats, Resveratrol, Sprague-Dawley, Stilbenes/*therapeutic use, Waghray Abhijeet
Chemopreventive doses of resveratrol do not produce cardiotoxicity in a rodent model of hepatocellular carcinoma.
Tags: *Chemoprevention, 2011, Analysis of Variance, Animal, Animal Studies, Animal/drug effects, Animals, Antioxidants, Behavior, Bishayee Anupam, Blotting, Booth Tristan D, Carcinoma, Cardiotoxicity, Cardiotoxins/*toxicity, Chemoprevention, Data Analysis Software, Department of Integrative Medical Sciences, Descriptive Statistics, Disease Models, Doppler, Dose-Response Relationship, Drug, Echocardiography, Feeding Behavior/drug effects, Female, Fisher's Exact Test, Funding Source, Heart – Drug Effects, Heart/drug effects/physiopathology, Hepatocellular – Prevention and Control, Hepatocellular/*drug therapy/pathology/physiopathology, Hepatocytes/drug effects/pathology, Hodnichak Cheryl M, Humans, Investigational new drugs, Liver Neoplasms/*drug therapy/pathology/physiopathology, Liver/drug effects/pathology/physiopathology, Luther Daniel J, Meszaros J Gary, NEOMED College of Medicine, Ohanyan Vahagn, Polyphenols – Therapeutic Use, Rats, Resveratrol, Shamhart Patricia E, Sisakian Hamayak, Sprague-Dawley, Stilbenes/*therapeutic use, Systole/drug effects, Western